Skip to main content
. 2025 Feb 8;13(4-6):95–103. doi: 10.1080/20468954.2025.2459582

Table 3.

The 52 comments that opposed the rule change.

Celia Leber; American Bar Association Intellectual Property Law Section; Japan Pharmaceutical Manufacturers Association; Stephanie Kwong; James Vetter; Canon Inc.; Carmichael IP and Kenneth J. Weatherwax; Innovation Alliance; Brandon Dube; Anonymous; Americans for Tax Reform; Qualcomm Incorporated; Allen Hoover; Nevro Corp; Patients For Affordable Drugs; Walter Phillips; EnQuanta, a VoiceIt Technologies Company; Clayton Howarth, P.C.; Advanced Medical Technology Association (AdvaMed); Patent Asset Management LLC; VENTUS THERAPEUTICS U.S., INC.; Dolby Laboratories; carol fletcher; Mark Syman; Deepak Malhotra; Alliance of U.S. Startups and Inventors for Jobs (”USIJ”); Cochlear Limited; IPValue Management, Inc.; Maf Holdings LLC; American Intellectual Property Law Association; Anonymous; Anonymous; Steven Hoffberg; Boston Intellectual Property Law Association; InterDigital, Inc.; Alfred Nugent; PTAB Bar Association; Unified Patents, LLC; Adeia Inc.; Andrew Berks; Tracy Neal; Fresenius Kabi, USA; Biotechnology Innovation Organization (BIO); Timothy Taylor; Nick Carbone; Daniel DiLorenzo; Meet LLC; Brian Boon; Matteo